MetLife Expands Usage-Based Auto Insurance Program with New App to Help Drivers Stay Safer and Lower Their Rates
The My Journey program app automatically tracks key driving behaviors, including total miles driven, time of day, road type and conditions, hard braking and harsh acceleration, and phone-based distracted driving, in order to arrive at a score for each trip. The app does so by leveraging the sensors that are built into smartphones to continuously analyze data as the car is in motion. The app calculates and immediately displays an overall score for each trip from 1-100, with 100 being the safest possible trip. A cumulative safety score is built as time goes by.
“Today’s drivers face more distractions on the road than ever, which increases the risk of driving and puts upward pressure on car insurance rates,” noted
Through the app, drivers can get a good idea of how they drive, as well as when and by what they are being distracted, so they can alter their behavior and become safer drivers. Drivers who enroll in the program immediately get ten percent off MetLife Auto & Home’s standard rates. After drivers spend six months in the program, MetLife Auto & Home will have enough driving data calculate a discount , and careful behavior will be rewarded with rates up to 30 percent off at the following renewal. Rates are not being increased as a result of information gathered, and the My Journey mobile app is free to those who enroll in the program.
“Our technology gives MetLife Auto & Home customers feedback that helps them become better drivers and makes the roads safer for all,” said
The smartphone-enabled My Journey program is now available in
About MetLife Auto & Home:
MetLife Auto & Home is one of the nation’s leading personal lines insurance groups, insuring more than 4 million autos and homes, and is affiliated with MetLife. For more information, visit www.metlife.com.
About MetLife
About TrueMotion
Headquartered in
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005689/en/
[email protected]
Source:



FDA’s Pazdur Outlines How Oncology Center of Excellence Will Promote Collaboration in AJMC®’s Evidence-Based Oncology™
Advisor News
- Affordability on Florida lawmakers’ minds as they return to the state Capitol
- Gen X confident in investment decisions, despite having no plan
- Most Americans optimistic about a financial ‘resolution rebound’ in 2026
- Mitigating recession-based client anxiety
- Terri Kallsen begins board chair role at CFP Board
More Advisor NewsAnnuity News
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
- Jackson Financial Inc. and TPG Inc. Announce Long-Term Strategic Partnership
More Annuity NewsHealth/Employee Benefits News
- In Snohomish County, new year brings changes to health insurance
- Visitor Guard® Unveils 2026 Visitor Insurance Guide for Families, Seniors, and Students Traveling to the US
- UCare CEO salary topped $1M as the health insurer foundered
- Va. Republicans split over extending
Va. Republicans split over extending health care subsidies
- Governor's proposed budget includes fully funding Medicaid and lowering cost of kynect coverage
More Health/Employee Benefits NewsLife Insurance News